Business Description
Lionco Pharmaceutical Group Co Ltd
ISIN : CNE1000022R8
Compare
Compare
Traded in other countries / regions
603669.China IPO Date
2015-05-28Description
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.46 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | -2.95 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.96 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45.4 | |||||
| 3-Year Book Growth Rate | -5.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.99 | |||||
| 9-Day RSI | 43.9 | |||||
| 14-Day RSI | 42.63 | |||||
| 6-1 Month Momentum % | -15.11 | |||||
| 12-1 Month Momentum % | -16.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.19 | |||||
| Quick Ratio | 3.02 | |||||
| Cash Ratio | 2.67 | |||||
| Days Inventory | 198.55 | |||||
| Days Sales Outstanding | 186.99 | |||||
| Days Payable | 232 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2 | |||||
| 3-Year Dividend Growth Rate | -35.5 | |||||
| Forward Dividend Yield % | 2 | |||||
| 5-Year Yield-on-Cost % | 3.57 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.83 | |||||
| Operating Margin % | -87.41 | |||||
| Net Margin % | -101.15 | |||||
| ROE % | -18.69 | |||||
| ROA % | -11.65 | |||||
| ROIC % | -21.12 | |||||
| ROC (Joel Greenblatt) % | -39.6 | |||||
| ROCE % | -13.54 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 22.23 | |||||
| PS Ratio | 16.66 | |||||
| PB Ratio | 3.21 | |||||
| Price-to-Tangible-Book | 3.62 | |||||
| EV-to-EBIT | -14.32 | |||||
| EV-to-EBITDA | -14.32 | |||||
| EV-to-Revenue | 13.9 | |||||
| EV-to-FCF | -20.26 | |||||
| Price-to-Projected-FCF | 2.73 | |||||
| Price-to-Net-Current-Asset-Value | 9.24 | |||||
| Price-to-Net-Cash | 18.48 | |||||
| Earnings Yield (Greenblatt) % | -6.99 | |||||
| Forward Rate of Return (Yacktman) % | -15.45 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Lionco Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 236.567 | ||
| EPS (TTM) (Â¥) | -0.33 | ||
| Beta | 1.41 | ||
| Volatility % | 25.84 | ||
| 14-Day RSI | 42.63 | ||
| 14-Day ATR (Â¥) | 0.135958 | ||
| 20-Day SMA (Â¥) | 5.1165 | ||
| 12-1 Month Momentum % | -16.48 | ||
| 52-Week Range (Â¥) | 4.81 - 7.63 | ||
| Shares Outstanding (Mil) | 721.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lionco Pharmaceutical Group Co Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lionco Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lionco Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Lionco Pharmaceutical Group Co Ltd(SHSE:603669)'s stock price today?
The current price of SHSE:603669 is ¥4.99. The 52 week high of SHSE:603669 is ¥7.63 and 52 week low is ¥4.81.
When is next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669)?
The next earnings date of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is .
Does Lionco Pharmaceutical Group Co Ltd(SHSE:603669) pay dividends? If so, how much?
The Dividend Yield %  of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is 2% (As of Today), Highest Dividend Payout Ratio of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) was 2.22. The lowest was 0. And the median was 0.68. The  Forward Dividend Yield % of Lionco Pharmaceutical Group Co Ltd(SHSE:603669) is 2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
